PHASE I TRIAL OF INTRATUMORAL ADMINISTRATION OF NIS-EXPRESSING STRAIN OF MEASLES VIRUS IN UNRESECTABLE OR RECURRENT MALIGNANT PERIPHERAL NERVE SHEATH

Mayo Clinic, Rochester MN

Investigators